Crossref
SGLT2 Inhibitors and Myocardial Infarction in Diabetes: Current Insights into Cardioprotective Mechanisms
The Egyptian Journal of Hospital Medicine · 01.01.2026 · 102 (1) · 1441-1447
DOI: 10.21608/ejhm.2026.493011 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.01.2026.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). SGLT2 Inhibitors and Myocardial Infarction in Diabetes: Current Insights into Cardioprotective Mechanisms. The Egyptian Journal of Hospital Medicine, 102(1), 1441-1447. https://doi.org/10.21608/ejhm.2026.493011
Vancouver
SGLT2 Inhibitors and Myocardial Infarction in Diabetes: Current Insights into Cardioprotective Mechanisms. The Egyptian Journal of Hospital Medicine. 2026;102(1):1441-1447. doi:10.21608/ejhm.2026.493011
BibTeX
@article{euvimed2026,
title = {SGLT2 Inhibitors and Myocardial Infarction in Diabetes: Current Insights into Cardioprotective Mechanisms},
journal = {The Egyptian Journal of Hospital Medicine},
year = {2026},
volume = {102},
number = {1},
pages = {1441--1447},
doi = {10.21608/ejhm.2026.493011}
}
EUVIMED